Delcath Systems Reports Executive & Director Changes

TL;DR

DELCATH SYSTEMS filed an 8-K about executive and director changes, plus new officer pay, on Feb 9, 2024, but specific details are missing.

AI Summary

DELCATH SYSTEMS, INC. filed an 8-K on February 14, 2024, reporting events that occurred on February 9, 2024. The filing indicates changes related to the departure or election of directors and certain officers, as well as new compensatory arrangements for officers. However, the provided text is incomplete and does not specify the names of individuals involved or the details of any compensation amounts.

Why It Matters

Changes in executive leadership and director roles, along with new compensation structures, can significantly influence a company's strategic direction, operational efficiency, and financial performance, impacting investor confidence.

Risk Assessment

Risk Level: medium — The filing indicates executive and director changes and new compensation, which can introduce uncertainty regarding future leadership and strategy, but specific details are not provided.

Key Players & Entities

• DELCATH SYSTEMS, INC. (company) — filer
• February 9, 2024 (date) — date of earliest event reported
• February 14, 2024 (date) — filing date

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value DCTH The Nasdaq Capital M

Filing Documents

• d788398d8k.htm (8-K) — 23KB
• 0001193125-24-036125.txt ( ) — 141KB
• dcth-20240209.xsd (EX-101.SCH) — 3KB
• dcth-20240209_lab.xml (EX-101.LAB) — 18KB
• dcth-20240209_pre.xml (EX-101.PRE) — 11KB
• d788398d8k_htm.xml (XML) — 4KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2024 DELCATH SYSTEMS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-16133 06-1245881 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 1633 Broadway , Suite 22C , New York , New York 10019 (Address of principal executive offices) (212) 489-2100 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value DCTH The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 12, 2024, John Purpura notified Delcath Systems, Inc. (the "Company") of his intent to retire as the Company's Chief Operating Officer. The Company is engaged in active discussions to appoint a new Chief Operating Officer with a preferred candidate identified. Mr. Purpura will remain with the Company until such time as his successor is named and has agreed to consult with the Company after he leaves. Additionally, on February 9, 2024, Roger Stoll notified the Company of his intent to retire from the board of directors of the Company (the "Board") and not stand for re-election at the Company's 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting"). Mr. Stoll has served the Board for over fourteen years and, after the recent FDA approval and commercial launch of Delcath's first product, Mr. Stoll decided that this was an appropriate time to retire from the Board. Mr. Stoll's retirement will become effective at the conclusion of the 2024 Annual Meeting. Mr. Stoll's decision to retire and not stand for re-election was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DELCATH SYSTEMS, INC. Date: February 14, 2024 By: /s/ Gerard Michel Name: Gerard Michel Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR